insights_auto
Kwa nini INCY imepungua kwa 3.47%?
Fahamu zaidichevron_right
INCY:NASDAQ
Incyte Corp
US$ 117.14
arrow_downward
-3.47%(-4.21) Siku 1
US$ 117.00
arrow_downward
-0.12% (-0.14)bedtimeBaada ya saa
Imefungwa: 1 Okt, 16:00:01 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya INCY...
Fungua
US$ 120.47
Juu
US$ 121.22
Chini
US$ 117.00
Mtaji wa soko
23.74B
Wastani wa kiasi cha mauzo
1.42M
Kiasi cha mauzo ya hisa
2.36M
Uwiano wa bei ya hisa na mapato kwa kila hisa
14.93
Juu kwa wiki 52
US$ 132.58
Chini kwa wiki 52
US$ 82.82
EPS
US$ 7.85
Beta
0.77
Hisa za wawekezaji
202.70M
Idadi ya wafanyakazi
elfu 3
Fungua
US$ 120.47
Juu
US$ 121.22
Chini
US$ 117.00
Mtaji wa soko
23.74B
Wastani wa kiasi cha mauzo
1.42M
Kiasi cha mauzo ya hisa
2.36M
Uwiano wa bei ya hisa na mapato kwa kila hisa
14.93
Juu kwa wiki 52
US$ 132.58
Chini kwa wiki 52
US$ 82.82
EPS
US$ 7.85
Beta
0.77
Hisa za wawekezaji
202.70M
Idadi ya wafanyakazi
elfu 3
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Benzinga
·
dakika 44 zilizopita
If You Invested $1000 In Incyte Stock 20 Years Ago, You Would Have This Much Today
Yahoo Finance
·
saa 3 zilizopita
Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment
GuruFocus
·
saa 9 zilizopita
INCY Maintained by Wells Fargo -- Price Target Raised to $128
AD HOC NEWS
·
saa 14 zilizopita
Incyte presents EADV data for Incyte stock
Wasifu
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
Kuhusu Incyte Corp
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 2.84
Lilianzishwa2002
Makao makuuWilmington, Delaware, Marekani
Sekta-
Tovutiincyte.com